Dr. Simeon Agwale, CEO of Innovative Biotech, announced that a Lassa fever vaccine developed by a Nigerian scientist successfully passed preclinical trials in mice and non-human primates, showing 100% protection against the Nigerian strain of the virus. The vaccine is licensed from the University of Maryland by Medigen USA, with...